elotuzumab	(100)(62)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLVESGGG LVQPGGSLRL SCAASGFDFS RYWMSWVRQA PGKGLEWIGE   50

INPDSSTINY APSLKDKFII SRDNAKNSLY LQMNSLRAED TAVYYCARPD  100

GNYWYFDVWG QGTLVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD  150

YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY  200

ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK  250

DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS  300

TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV  350

YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL  400

DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK   449

Light chain / Chaone lygire / Cadena ligera

DIQMTQSPSS LSASVGDRVT ITCKASQDVG IAVAWYQQKP GKVPKLLIYW   50

ASTRHTGVPD RFSGSGSGTD FTLTISSLQP EDVATYYCQQ YSSYPYTFGQ  100

GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV  150

DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG  200

LSSPVTKSFN RGEC                                         214

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	146-202	263-323	369-427

	22??-96??	146??-202??	263??-323??	369??-427??

Intra-L	23?-88?	134?-194?



	23???-88???	134???-194???



Inter-H-L	222-214?	222??-214???



Inter-H-H	228-228??	231-231??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

299, 299??

Molecular formula	C6476H9982N1714O2016S42

Description

immunoglobulin G1-kappa, anti-[Homo sapiens SLAM family member 7 (SLAM7,
CD2 subset 1, CS1, CD2-like receptor-activating cytotoxic cells, CRACC,
19A24, CD319), humanized monoclonal antibody;

gamma1 heavy chain (1-449) [humanized VH (Homo sapiens IGHV3-74*01
(81.60%) -IGHJ2*01, R120>Q) [8.8.12] (1-119) -Homo sapiens IGHG1*01
(120-449)], (222-214?)-disulfide with kappa light chain (1?-214?)
[humanized V-KAPPA (Homo sapiens IGKV1-27*01 (84.20%) -IGKJ2*01, L124>V)
[6.3.9] (1?-107?) -Homo sapiens IGKC*01 (108?-214?)];
(228-228??:231-231??)-bisdisulfide dimer 

	

WHO 

International Nonproprietary Names Programme	

9074

December 2008

Page 1/1

		

